Vericel Corp financial data

Symbol
VCEL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
64 Sidney St., Cambridge, MA
State of incorporation
MI
Fiscal year end
December 31
Former names
AASTROM BIOSCIENCES INC (to 11/14/2014)
Latest financial report
10-Q - Q2 2024 - Aug 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 481 % -13.2%
Quick Ratio 33.4 % -30.5%
Debt-to-equity 54.9 % +25.5%
Return On Equity 0.35 %
Return On Assets 0.22 %
Operating Margin -1.78 % +78.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49M shares +2.91%
Common Stock, Shares, Outstanding 48.9M shares +2.62%
Entity Public Float 1.77B USD +50.6%
Common Stock, Value, Issued 655M USD +7.01%
Weighted Average Number of Shares Outstanding, Basic 48.7M shares +2.34%
Weighted Average Number of Shares Outstanding, Diluted 48.7M shares +2.34%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 215M USD +20.4%
Revenue from Contract with Customer, Excluding Assessed Tax 215M USD +20.5%
Research and Development Expense 24.4M USD +17.4%
Operating Income (Loss) -3.82M USD +74.3%
Nonoperating Income (Expense) 5.42M USD +127%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.95M USD +39.8%
Income Tax Expense (Benefit) -286K USD -1462%
Net Income (Loss) Attributable to Parent 789K USD +6.73%
Earnings Per Share, Basic 0.02 USD/shares +9.09%
Earnings Per Share, Diluted 0.02 USD/shares +9.09%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 50.3M USD +16.9%
Accounts Receivable, after Allowance for Credit Loss, Current 48M USD +25.3%
Inventory, Net 14.9M USD +7.23%
Other Assets, Current 6.43M USD +27.5%
Assets, Current 197M USD +7.94%
Operating Lease, Right-of-Use Asset 73M USD -2.72%
Other Assets, Noncurrent 664K USD -44.5%
Assets 377M USD +21.3%
Accounts Payable, Current 25.2M USD +75.1%
Employee-related Liabilities, Current 4.26M USD +23.9%
Accrued Liabilities, Current 12.9M USD -7.98%
Liabilities, Current 43.9M USD +23.2%
Operating Lease, Liability, Noncurrent 89.8M USD +17.9%
Other Liabilities, Noncurrent 198K USD +607%
Liabilities 134M USD +19.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -273K USD +56%
Retained Earnings (Accumulated Deficit) -412M USD +0.19%
Stockholders' Equity Attributable to Parent 243M USD +22.1%
Liabilities and Equity 377M USD +21.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 7.2M USD -8.37%
Net Cash Provided by (Used in) Financing Activities 2.13M USD +1887%
Net Cash Provided by (Used in) Investing Activities -25.5M USD -1009%
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 48.9M shares +2.62%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -16.1M USD -250%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 75.9M USD +7.11%
Deferred Tax Assets, Valuation Allowance 49.8M USD +5.21%
Deferred Tax Assets, Gross 70.7M USD +17.5%
Operating Lease, Liability 85M USD
Depreciation 4.4M USD +10%
Payments to Acquire Property, Plant, and Equipment 14M USD +892%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.14M USD +5.89%
Lessee, Operating Lease, Liability, to be Paid 158M USD
Operating Lease, Liability, Current 5.79M USD -19.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 13.7M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 10.7M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +18.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 49.6M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 14M USD
Deferred Tax Assets, Operating Loss Carryforwards 4.51M USD -35.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 14.4M USD
Depreciation, Depletion and Amortization 1.38M USD +19%
Interest Expense 608K USD +23.3%